Yield10 Bioscience Inc reports results for the quarter ended in March - Earnings Summary

Yield10 Bioscience

11/05/2022 23:39

* Yield10 Bioscience Inc  YTEN.OQ  reported a quarterly
adjusted
loss of 68 cents​​ per share for the quarter ended in March. The
mean expectation of four analysts for the quarter was for a loss
of 65 cents per share.
    * Revenue fell 24% to $149.00 thousand from a year ago; 
analysts
expected $173.00 thousand. 
    * Yield10 Bioscience Inc's reported EPS for the quarter was
a loss
of 68 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Yield10 Bioscience Inc shares had fallen by 54.3% this
quarter and lost 50.8% so far this year.
    * The company reported a quarterly loss of $3.33 million.
    * Wall Street's median 12-month price target for Yield10
Bioscience Inc is $10.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 11 at 10:39 p.m.  ​All
figures in US dollars unless otherwise stated